Sanegene Bio
Woburn
About Sanegene Bio
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $240.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2025)
- Website: sanegenebio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sanegene-bio-30938 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.